Blog
RSS FeedPosted by Michael Wonder on 05 Feb 2024
Cheaper medicines for advanced melanoma and multiple sclerosis
5 February 2024 - From 1 February 2024, Australians with advanced melanoma and relapsing-remitting multiple sclerosis will have access to ...
Posted by Michael Wonder on 31 Jan 2024
Schedule of Pharmaceutical Benefits - 1 February 2024
1 February 2024 - The February 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Jan 2024
2024 PBS post-market review framework
31 January 2024 - The 2024 post-market review framework is now available. ...
Posted by Michael Wonder on 29 Jan 2024
Updates to the HTA Review: options paper for Consultation 2 published
25 January 2024 - The Options paper for Consultation 2 is now available on the Office of Health Technology Assessment consultation ...
Posted by Michael Wonder on 26 Jan 2024
Outcomes from the December 2023 PBAC intracycle meeting
25 January 2024 - The outcomes from the December 2023 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 22 Jan 2024
Australians save $250 million thanks to Albanese Government cheaper medicines
22 January 2024 - Australians have saved $250 million on cheaper medicines in 2023 thanks to the Albanese Government. ...
Posted by Michael Wonder on 21 Jan 2024
Advanced melanoma treatment to be added to Pharmaceutical Benefits Scheme
21 January 2024 - Treatment for advanced melanoma is set to become cheaper under the Pharmaceutical Benefits Scheme in the ...
Posted by Michael Wonder on 18 Jan 2024
Updates to the HTA Policy and Methods Review Reference Committee (18 January 2024)
18 January 2024 - Communiques for three HTA Review Reference Committee meetings held in December 2023 are now available. ...
Posted by Michael Wonder on 17 Jan 2024
PBAC - 2023 in review
18 January 2024 - In contrast to New Zealand, 2023 saw many new medicines listed on the PBS. ...
Posted by Michael Wonder on 14 Jan 2024
DoH publishes revised agenda for March 2024 PBAC meeting (version 3)
5 January 2024 - The Department of Health has published a revised agenda (version 3) for the March 2024 PBAC ...
Posted by Michael Wonder on 14 Jan 2024
Public summary documents (first time decisions not to recommend and deferrals) – September 2023 PBAC meeting
12 January 2024 - The public summary documents (first time decisions not to recommend and deferrals) from the September 2023 PBAC ...
Posted by Michael Wonder on 04 Jan 2024
Updates to the HTA review research and analysis papers collection: draft HTA expert papers published
4 January 2024 - Two draft papers developed to support the deliberations of the HTA Review Reference Committee have been ...
Posted by Michael Wonder on 02 Jan 2024
Expanded PBS listings make vital treatments more affordable
2 January 2024 - From 1 January 2024, Australians with advanced ovarian cancer, CLL, SLL, cystic fibrosis and atypical haemolytic uraemic ...
Posted by Michael Wonder on 01 Jan 2024
Schedule of Pharmaceutical Benefits - 1 January 2024
1 January 2024 - The January 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 28 Dec 2023
Public Summary Documents – September 2023 PBAC meeting
22 December 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2023 PBAC ...